Martino, David https://orcid.org/0000-0001-6823-4696
Kresoje, Nina
Amenyogbe, Nelly
Ben-Othman, Rym
Cai, Bing
Lo, Mandy
Idoko, Olubukola
Odumade, Oludare A.
Falsafi, Reza
Blimkie, Travis M.
An, Andy
Shannon, Casey P. https://orcid.org/0000-0002-5687-3156
Montante, Sebastiano
Dhillon, Bhavjinder K. https://orcid.org/0000-0002-9696-1556
Diray-Arce, Joann https://orcid.org/0000-0003-2183-4269
Ozonoff, Al https://orcid.org/0000-0003-4233-5899
Smolen, Kinga K. https://orcid.org/0000-0001-8650-3693
Brinkman, Ryan R.
McEnaney, Kerry https://orcid.org/0000-0002-0378-3456
Angelidou, Asimenia https://orcid.org/0000-0002-6716-6561
Richmond, Peter
Tebbutt, Scott J. https://orcid.org/0000-0002-7908-1581
,
Kampmann, Beate
Levy, Ofer https://orcid.org/0000-0002-5859-1945
Hancock, Robert E. W. https://orcid.org/0000-0001-5989-8503
Lee, Amy H. Y.
Kollmann, Tobias R. https://orcid.org/0000-0003-2403-9762
Funding for this research was provided by:
Future Health Research Innovation Fund, IG2021
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (1K08AI168487, U19AI118608, U19AI168643)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 28 November 2023
Accepted: 3 September 2024
First Online: 17 September 2024
Competing interests
: OL is the inventor of patents helped by Boston Children’s Hospital relating to vaccine adjuvants (EP3709998A1) and human in vitro systems that model responses to immunomodulators and vaccines (e.g., US20150152385A1). Hi is an advisor to GlaxoSmithKline (GSK) and Hillevax and a cofounder of and advisor to Ovax Inc. The remaining authors declare no competing interests.